Companies: 10,795·Total market cap: $144.5T
aTyr Pharma, Inc.

aTyr Pharma, Inc.

ATYRNASDAQHealthcare● Active
$0.44
$-0.03(-5.94%)
Market Cap$43348436
P/E Ratio
52W High$7.29
52W Low$0.395

aTyr Pharma, Inc.(ATYR)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

atyr · 股价预测 · 10 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 10 位华尔街分析师

SellBuy

Hold

10 位分析师

共识

评级分布

Strong Buy
0
Buy
3
Hold
7
Sell
0
Strong Sell
0
合计: 10 · 买入占比: 30.0%

12 个月目标价

High

$17.00

Consensus

$5.13

+1060.4% upside

Low

$1.00

Median: $1.25 · Last Close: $0.44

aTyr Pharma, Inc.(ATYR)的分析师共识为 Hold,基于过去 3 个月内 10 位华尔街分析师的评级。ATYR 的 12 个月平均目标价为 $5.13,相对当前价 $0.44 代表 +1060.4% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

Bear

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$0.425.00%

1-day model range: $0.41–$0.43. Peak: $0.43 (-5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%21%79%
0Buy
3Neutral
11Sell
RSI (14)38.5Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · ATYR · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$0.49SELL
MA 10$0.50SELL
MA 20$0.52SELL
MA 50$0.71SELL
MA 100$0.79SELL
MA 200$0.00NEUTRAL
Current $ATYR · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.48SELL
EMA 10$0.50SELL
EMA 20$0.55SELL
EMA 50$0.66SELL
EMA 100$0.74SELL
EMA 200$0.00NEUTRAL
Current $ATYR · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Freedom Broker2026-05-20
Upgrade ↑
HoldBuy
RBC Capital2025-11-07
Maintains
Sector PerformSector Perform
Wells Fargo2025-09-16
Downgrade ↓
OverweightEqual Weight
RBC Capital2025-09-16
Downgrade ↓
OutperformSector Perform
Cantor Fitzgerald2025-09-15
Downgrade ↓
OverweightNeutral
LUCID CAPITAL MARKETS2025-09-15
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2025-09-15
Downgrade ↓
BuyNeutral
Leerink Partners2025-09-15
Downgrade ↓
OutperformMarket Perform
Jones Trading2025-09-15
Downgrade ↓
BuyHold
Jefferies2025-08-22
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on aTyr Pharma, Inc. (ATYR) stock. Of the recent 27 rating actions, 1 were upgrades and 7 were downgrades. 10 analysts currently cover ATYR.

分析师推荐趋势

Buy ratings11
Hold ratings00
Sell ratings00

ATYR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$4M

↓ 90.8% YoY

Revenue Next Year

$9M

↑ 127.9% YoY

EPS This Year

$-0.57

EPS Next Year

$-0.62

↑ 8.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast ATYR EPS of $-0.57 for the current fiscal year, based on estimates from 4 analysts. The ATYR revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

ATYR 股价预测由两类独立数据源支撑:来自 10 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ATYR 的共识目标价为 $5.13(+1060.4% 上行空间),分析师共识为 Hold。

ATYR 的短期预测(明日)为 $0.42(-5.00%)。

aTyr Pharma, Inc. 在 NASDAQ 上市,代码 ATYR。ATYR 在 2027 年的整体展望偏中性/分化,在覆盖分析师中约 30% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

ATYR 预测 · 8 个问题

根据 10 位华尔街分析师,ATYR 的 12 个月平均目标价为 $5.13,最高 $17.00、最低 $1.00。若有图表,中位目标价可在上方查看。相对当前价 $0.44,隐含约 +1060.4% 的上行空间。

ATYR 目标价ATYR 分析师目标价ATYR 12个月目标价目标价 ATYR

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.